# Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial

> **NCT06738433** · EARLY_PHASE1 · COMPLETED · sponsor: **AB Biotek** · enrollment: 34 (actual)

## Conditions studied

- Constipation

## Interventions

- **DIETARY_SUPPLEMENT:** ABB i5
- **DIETARY_SUPPLEMENT:** ABB C24

## Key facts

- **NCT ID:** NCT06738433
- **Lead sponsor:** AB Biotek
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-25
- **Primary completion:** 2024-04-04
- **Final completion:** 2024-04-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06738433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06738433, "Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06738433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*